Cargando…
R-carvedilol, a potential new therapy for Alzheimer’s disease
For decades, the amyloid cascade hypothesis has been the leading hypothesis in studying Alzheimer’s disease (AD) pathology and drug development. However, a growing body of evidence indicates that simply removing amyloid plaques may not significantly affect AD progression. Alternatively, it has been...
Autores principales: | Yao, Jinjing, Chen, S. R. Wayne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756136/ https://www.ncbi.nlm.nih.gov/pubmed/36532759 http://dx.doi.org/10.3389/fphar.2022.1062495 |
Ejemplares similares
-
Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease
por: Yao, Jinjing, et al.
Publicado: (2023) -
Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017) -
Carvedilol Exerts Neuroprotective Effect on Rat Model of Diabetic Neuropathy
por: Magadmi, Rania M., et al.
Publicado: (2021) -
Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
por: Cenini, Giovanna, et al.
Publicado: (2019) -
Therapeutic potential of mGluR5 targeting in Alzheimer's disease
por: Kumar, Anil, et al.
Publicado: (2015)